Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline

Journal of Clinical Pharmacology
Borje DarpoPhilip T Sager

Abstract

Proarrhythmias due to drug-induced QT prolongation are the second most common cause for drug withdrawal and have caused increasing concern. Two new International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines were recently endorsed in which nonclinical (S7B) and clinical (E14) methodologies are discussed and guidance is given to the industry. This commentary describes the key components of the E14 document, the impact of nonclinical testing on the clinical program, the thorough QT study, and the impact of its result on late-stage development. The studies described in S7B and E14 will contribute to a better understanding of the link between nonclinical assays and QT prolongation in humans. Differences in interpretation among individual regulators in the major regions with respect to measures proposed in the E14 guideline might impact regional regulatory decisions. These differences include the value of nonclinical assays for the subsequent clinical testing and how predictive a negative thorough QT study result is for proarrhythmic risk in patients.

References

Mar 24, 1993·JAMA : the Journal of the American Medical Association·P K HonigL R Cantilena
Jul 25, 1996·The New England Journal of Medicine·D K Wysowski, J Bacsanyi
Jun 1, 1996·British Journal of Clinical Pharmacology·J L DemolisP Jaillon
Feb 4, 1998·Obesity Research·D NagyS B Heymsfield
Dec 2, 1998·Clinical Pharmacology and Therapeutics·A D van HaarstA F Cohen
Aug 12, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Y G Yap, A J Camm
Oct 20, 1999·The American Journal of Medicine·A M WalkerN A Dreyer
Dec 1, 1999·Clinical Pharmacology and Therapeutics·K T KivistöP J Neuvonen
Feb 17, 2001·Clinical Pharmacology and Therapeutics·J L DémolisC Funck-Brentano
Apr 11, 2001·Pflügers Archiv : European journal of physiology·J FrederiksA V Bruschke
May 3, 2001·Journal of Cardiovascular Electrophysiology·M Malik
Jun 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M Malik, A J Camm
Sep 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M WhiteR Quintiliani
May 29, 2002·Fundamental & Clinical Pharmacology·Rashmi R Shah
Jun 21, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·Jean T BarbeyDouglas P Zipes
Sep 5, 2002·British Journal of Clinical Pharmacology·Rashmi R Shah
Oct 23, 2002·Circulation·André DiedrichItalo Biaggioni
Nov 15, 2002·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Corina DotaGunnar Fager
Mar 7, 2003·Clinical Pharmacology and Therapeutics·Jean-Louis DémolisChristian Funck-Brentano
Apr 12, 2003·Pacing and Clinical Electrophysiology : PACE·Corina D DotaGunnar Fager
Apr 24, 2003·Clinical Pharmacology and Therapeutics·Gary J NoelRobert Abels
Nov 5, 2003·Heart·Yee Guan Yap, A John Camm
Jan 21, 2004·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Nenad SarapaArthur J Moss
Apr 16, 2004·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Nkechi E AzieJoseph C Fleishaker
May 21, 2005·Clinical Pharmacology and Therapeutics·Marek Malik
May 21, 2005·Clinical Pharmacology and Therapeutics·Fabrice ExtramianaAntoine Leenhardt
May 19, 2006·Journal of Clinical Pharmacology·Borje DarpoDiane K Jorkasky

❮ Previous
Next ❯

Citations

Nov 2, 2013·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Ayman A Gouda, Alaa S Amin
Sep 25, 2007·European Journal of Clinical Pharmacology·Réginald HulhovenArmel Stockis
Jun 4, 2010·Cancer Chemotherapy and Pharmacology·Anthony W TolcherPavur R Sundaresan
Jul 9, 2011·Cancer Chemotherapy and Pharmacology·R ThertulienA P Staddon
Aug 11, 2012·Cancer Chemotherapy and Pharmacology·Richard M LushAnthony Tolcher
Apr 24, 2013·Cancer Chemotherapy and Pharmacology·Daryl SonnichsenFrank G Haluska
Dec 4, 2009·European Journal of Epidemiology·Charlotte van NoordBruno H Ch Stricker
Dec 18, 2012·Journal of Clinical Monitoring and Computing·Makito OjiKoji Sumikawa
Feb 22, 2012·Journal of Pharmacokinetics and Pharmacodynamics·Philippe Grosjean, Saïk Urien
Oct 29, 2008·Pharmaceutical Research·Mei-Ling Chen, Vincent H L Lee
Feb 28, 2004·Science and Engineering Ethics·Jeremy Sugarman
Sep 18, 2007·Science and Engineering Ethics·Joanna Rózyńska, Marek Czarkowski
Dec 1, 2009·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·M Sudhakara RaoP S N Murthy
Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Glenn F CarlsonKathleen Butler
Jun 4, 2013·European Journal of Medicinal Chemistry·Anwar RayanAmiram Goldblum
Jan 2, 2014·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Hudson Caetano PoloniniNádia Rezende Barbosa Raposo
May 30, 1998·The American Journal of Cardiology·S AurecchiaS Sobel
Sep 29, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J F GilmerJ M Clancy
Jun 23, 2009·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·E Jacqz-Aigrain, C Lassalle
Apr 2, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Robert Roskar, Vojko Kmetec
May 13, 2008·Journal of Biopharmaceutical Statistics·Marilyn A AginPhilip Sager
May 13, 2008·Journal of Biopharmaceutical Statistics·Anastasia StylianouKimberley Stephens
May 13, 2008·Journal of Biopharmaceutical Statistics·Joanne Zhang
May 13, 2008·Journal of Biopharmaceutical Statistics·Yi TsongWen Jen Chen
May 13, 2008·Journal of Biopharmaceutical Statistics·Joanne Zhang, Stella G Machado
Apr 2, 2010·Journal of Biopharmaceutical Statistics·Duolao WangAlan John Camm
Apr 2, 2010·Journal of Biopharmaceutical Statistics·Jie Chen, Xin Zhao
Apr 2, 2010·Journal of Biopharmaceutical Statistics·Balakrishna HosmaneYi-Lin Chiu
Oct 19, 2012·Journal of Biopharmaceutical Statistics·Duolao WangRadivoj Arezina
Nov 21, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Dan M RodenDawood Darbar
Mar 31, 2010·Antimicrobial Agents and Chemotherapy·Edward O'MaraOrrin Devinsky
Feb 14, 2013·Antimicrobial Agents and Chemotherapy·Joan M Korth-BradleySylvester Pawlak
Jan 30, 2013·Antimicrobial Agents and Chemotherapy·Todd A RiccobeneLily Llorens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.